IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer

Differentiated thyroid cancer (DTC) is the most frequent endocrine tumor with a good prognosis after primary treatment in most cases. By contrast, 30–40% of patients with metastatic DTC are unresponsive to (131)I radioactive iodide (RAI) treatment due to tumor dedifferentiation. Currently, underlyin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Crezee, Thomas, Tesselaar, Marika H., Jaeger, Martin, Rabold, Katrin, Corver, Willem E., Morreau, Hans, Van Engen-Van Grunsven, Adriana C.H., Smit, Jan W.A., Netea-Maier, Romana T., Plantinga, Theo S.
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2021
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8200939/
https://ncbi.nlm.nih.gov/pubmed/34149901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12851
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados